The Chicago Entrepreneur

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis’ Pluvicto.

Previous post Manufacturing activity expands in New York region for first time in almost a year
Next post Student-loan borrowers in their 50s and older are begging lawmakers: Don’t let us die with this debt